General Information of the Compound
| Compound ID |
CP0424724
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-(1-Methyl-3,4-dihydronaphthalen-2-yl)-pyridine
Show/Hide
|
||||||||||||||||||
| Synonyms |
2-yl)-pyridine
3-(1-Methyl-3,4-dihydro-naphthalen-
3-(1-methyl-3,4-dihydronaphthalen-2-yl)-pyridine
3-(1-methyl-3,4-dihydronaphthalen-2-yl)pyridine
3614-50-4
AC-20696
AC1O70HB
ACM3614504
AKOS015965701
BDBM8892
CHEMBL206283
CTK4H5985
DTXSID90424897
Dihydronaphthalene 6
KB-232450
SCHEMBL4514804
ZINC13684515
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H15N
|
||||||||||||||||||
| Molecular Weight |
221.303
|
||||||||||||||||||
| Canonical SMILES |
CC1=C(CCc2ccccc12)c1cccnc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H15N/c1-12-15-7-3-2-5-13(15)8-9-16(12)14-6-4-10-17-11-14/h2-7,10-11H,8-9H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
WBEMJRFRGOAAJI-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03119, Cytochrome P450 11B1, mitochondrial
Protein ID: PT03120, Cytochrome P450 11B2, mitochondrial
Clinical Information about the Compound